TAR-DNA binding protein-43 and alterations in the hippocampus

Journal of Neural Transmission

Volumn 118, Issue 5, 2011, Pages 683-689

  Rauramaa, Tuomas ^a,b   Pikkarainen, Maria ^b   Englund, Elisabet ^c   Ince, Paul G ^d   Jellinger, Kurt ^e   Paetau, Anders ^f   Alafuzoff, Irina ^a,b,g  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hippocampal alterations; Hyperphosphorylated ; Immunohistochemistry; p62; Post mortem; TAR DNA binding protein 43

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN P62; TAR DNA BINDING PROTEIN; TAU PROTEIN;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN DAMAGE; CONTROLLED STUDY; DENTATE GYRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; GRANULAR CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATERAL GENICULATE BODY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TAUOPATHY; VASCULAR LESION;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; BRAIN DISEASES; CHI-SQUARE DISTRIBUTION; DNA-BINDING PROTEINS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VASCULAR DISEASES;

EID: 79956214776     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0574-5     Document Type: Article

References (32)

1. I Alafuzoff S Helisalmi A Mannermaa P Riekkinen Sr H Soininen 1999 Beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients Stroke 30 613 618
2. I Alafuzoff T Arzberger S Al-Sarraj, et al. 2008 Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium Brain Pathol 18 484 496 18371174
3. I Alafuzoff DR Thal T Arzberger, et al. 2009 Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium Acta Neuropathol 117 309 320 19184666 10.1007/s00401-009-0485-4 1:CAS:528: DC%2BD1MXitFSqtrg%3D
4. I Alafuzoff PG Ince T Arzberger, et al. 2009 Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium Acta Neuropathol 117 635 652 19330340 10.1007/s00401-009-0523-2 1:CAS:528:DC%2BD1MXlvFOksLs%3D
5. C Amador-Ortiz WL Lin Z Ahmed, et al. 2007 TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease Ann Neurol 61 435 445 17469117 10.1002/ana.21154 1:CAS:528:DC%2BD2sXnsFKmur8%3D (Pubitemid 46878771)
6. T Arai M Hasegawa H Akiyama, et al. 2006 TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Biochem Biophys Res Commun 351 602 611 17084815 10.1016/j.bbrc.2006.10.093 1:CAS:528:DC%2BD28Xht1SmsbbJ (Pubitemid 44708852)
7. T Arai IR Mackenzie M Hasegawa, et al. 2009 Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies Acta Neuropathol 117 125 136 19139911 10.1007/s00401-008-0480-1 1:CAS:528:DC%2BD1MXhtVCltL0%3D
8. H Braak I Alafuzoff T Arzberger, et al. 2006 Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry Acta Neuropathol 112 389 404 16906426 10.1007/s00401-006- 0127-z (Pubitemid 44469160)
9. AS Chen-Plotkin VM Lee JQ Trojanowski 2010 TAR DNA-binding protein 43 in neurodegenerative disease Nat Rev Neurol 6 4 211 220 20234357 10.1038/nrneurol.2010.18 1:CAS:528:DC%2BC3cXksVehurc%3D
10. SH Freeman T Spires-Jones BT Hyman, et al. 2008 TAR-DNA binding protein 43 in Pick disease J Neuropathol Exp Neurol 67 62 67 18091558 10.1097/nen.0b013e3181609361 1:CAS:528:DC%2BD1cXhtlyju7Y%3D
11. H Fujishiro H Uchikado T Arai, et al. 2009 Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease Acta Neuropathol 117 151 158 19039597 10.1007/s00401-008-0463-2 1:CAS:528:DC%2BD1MXhtVCltLo%3D
12. F Geser VM Lee JQ Trojanowski 2010 Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies Neuropathology 30 2 103 112 20102519 10.1111/j.1440-1789.2009.01091.x
13. KJ Hatanpää EH Bigio NJ Cairns, et al. 2008 TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study J Neuropathol Exp Neurol 67 271 279 18379440 10.1097/NEN.0b013e31816a12a6 (Pubitemid 351507483)
14. S Higashi E Iseki R Yamamoto, et al. 2007 Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies Brain Res 1184 284 294 17963732 10.1016/j.brainres.2007.09.048 1:CAS:528:DC%2BD2sXhtlyrs7jL (Pubitemid 350160566)
15. WT Hu KA Josephs DS Knopman, et al. 2008 Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease Acta Neuropathol 116 215 220 18592255 10.1007/s00401-008-0400-4 1:CAS:528:DC%2BD1cXosVyisLk%3D
16. KA Josephs JL Holton MN Rossor, et al. 2004 Frontotemporal lobar degeneration and ubiquitin immunohistochemistry Neuropathol Appl Neurobiol 30 369 373 15305982 10.1111/j.1365-2990.2003.00545.x 1:STN:280: DC%2BD2cvgt1yjsg%3D%3D (Pubitemid 39120298)
17. KA Josephs JL Whitwell DS Knopman, et al. 2008 Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype Neurology 70 1850 1857 18401022 10.1212/01.wnl.0000304041.09418.b1 1:CAS:528:DC%2BD1cXhtFags7jE (Pubitemid 351653955)
18. A Kadokura T Yamazaki CA Lemere, et al. 2009 Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology Neuropathology 29 566 573 19422539 10.1111/j.1440-1789.2009.01017.x
19. E Kuusisto L Parkkinen I Alafuzoff 2003 Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62 J Neuropathol Exp Neurol 62 1241 1253 14692700 1:CAS:528:DC%2BD2cXht1Onsw%3D%3D (Pubitemid 37494193)
20. E Kuusisto T Kauppinen I Alafuzoff 2008 Use of p62/SQSTM1 antibodies for neuropathological diagnosis Neuropathol Appl Neurobiol 34 169 180 17961133 10.1111/j.1365-2990.2007.00884.x 1:STN:280:DC%2BD1c7ks1Ojsw%3D%3D (Pubitemid 351327959)
21. IR Mackenzie M Neumann EH Bigio, et al. 2010 Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update Acta Neuropathol 119 1 4 19924424 10.1007/s00401-009-0612-2
22. FJ Mateen KA Josephs 2009 TDP-43 is not present in brain tissue of patients with schizophrenia Schizophr Res 108 297 298 18829261 10.1016/j.schres.2008.08.033
23. G McKhann D Drachman M Folstein, et al. 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944 6610841 1:STN:280:DyaL2c3ks1altQ%3D%3D (Pubitemid 14076461)
24. H Nakashima-Yasuda K Uryu J Robinson, et al. 2007 Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases Acta Neuropathol 114 221 229 17653732 10.1007/s00401-007-0261-2 1:CAS:528:DC%2BD2sXosFKrsLs%3D (Pubitemid 47226148)
25. PT Nelson EL Abner FA Schmitt, et al. 2010 Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons Brain Pathol 20 66 79 19021630 10.1111/j.1750-3639.2008.00244.x
26. M Neumann DM Sampathu LK Kwong, et al. 2006 Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 130 133 17023659 10.1126/science.1134108 1:CAS:528:DC%2BD28XhtVCiurrL (Pubitemid 44547757)
27. L Parkkinen H Soininen M Laakso, et al. 2001 Alpha-synuclein pathology is highly dependent on the case selection Neuropathol Appl Neurobiol 27 314 325 11532162 10.1046/j.0305-1846.2001.00342.x 1:STN:280:DC%2BD3MvovFehuw%3D%3D (Pubitemid 32758618)
28. HL Paulson 2009 The spinocerebellar ataxias J Neuroophthalmol 29 227 237 19726947
29. M Tolnay F Clavaguera 2004 Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies Neuropathology 24 269 283 15641585 10.1111/j.1440-1789.2004.00591.x (Pubitemid 39664748)
30. K Uryu H Nakashima-Yasuda MS Forman, et al. 2008 Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies J Neuropathol Exp Neurol 67 555 564 18520774 10.1097/NEN.0b013e31817713b5 1:CAS:528:DC%2BD1cXotVant7g%3D (Pubitemid 351787082)
31. HY Wang IF Wang J Bose CK Shen 2004 Structural diversity and functional implications of the eukaryotic TDP gene family Genomics 83 130 139 14667816 10.1016/S0888-7543(03)00214-3 1:CAS:528:DC%2BD3sXpsFeltLk%3D (Pubitemid 37518267)
32. DR Williams AJ Lees 2009 Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges Lancet Neurol 8 270 279 19233037 10.1016/S1474-4422(09)70042-0